Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/09/2003US20030190641 Live cell method for observing cellular processes
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190633 Support for fixing nucleotide and process for producing the same
10/09/2003US20030190628 Beads, preparing method for the same, flow cytometer and program
10/09/2003US20030190624 For assessing kidney function; diagnosing, staging, treating and evaluating therapies for such disorders
10/09/2003US20030190616 Differentially methylated sequences in pancreatic cancer
10/09/2003US20030190615 DPI-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders
10/09/2003US20030190614 Non-human primate Fc receptors and methods of use
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190603 Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networks
10/09/2003US20030190602 Cell-based detection and differentiation of disease states
10/09/2003US20030190601 Useful for diagnosis and therapy, research tools for drug discovery
10/09/2003US20030190600 Used in treatments for bacterial infections, dysentery, angiogenesis, immune cell mediated disease
10/09/2003US20030190599 Combinational Biosensor
10/09/2003US20030190597 For drug screening and development, exposing to a compound that paralyzes or kills nematoda
10/09/2003US20030190407 Comprises impregnated carrier layer having communicating pore space with probe contained therein formed of biomolecules
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
10/09/2003US20030190313 Immunoglobulins; lipopolysaccharides; immunoassay; kits
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003US20030190266 Odor eliminating fiber structure having indicator
10/09/2003US20030190262 Employ luminescence-quenching to produce a signal indicative of oxygen concentration
10/09/2003US20030190261 Detects concentration of gas circulating inside an outlet-side piping in high accurate manner; contains a through hole in an inner wall of outlet side piping and a gas inlet portion with one face open within the outlet-side piping
10/09/2003US20030189969 Method to calculate fuel DI number from a measured curve
10/09/2003US20030189968 Method and apparatus for evaluating the phase changing function of fabric
10/09/2003US20030189850 Cell array system
10/09/2003US20030188970 Electrophoresis separation apparatus and its used a hand-held electrophoresis detection device
10/09/2003US20030188953 Method and apparatus for inspecting articles of glassware
10/09/2003US20030188591 Concrete test specimen method and apparatus
10/09/2003US20030188590 Apparatus and methods for determining self-weight consolidation and other properties of media
10/09/2003US20030188570 System and method for determining oil grade
10/09/2003US20030188568 Gas sensor, gas sensor installation structure, and method for installing gas sensor
10/09/2003US20030188427 Process for producing an electrochemical biosensor
10/09/2003DE10215909C1 Verfahren und Vorrichtung zur Überwachung der Wasserstoffkonzentration Method and apparatus for monitoring the concentration of hydrogen
10/09/2003CA2738579A1 Improving performance of an analyte monitoring device
10/09/2003CA2724741A1 Integrated sample testing meter
10/09/2003CA2488233A1 Cell population with identification codes and method of screening cell population
10/09/2003CA2481376A1 Novel proteins and nucleic acids encoding same
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2480770A1 Biochip sensor surface carrying polyethylene glycolated nanoparticles
10/09/2003CA2480694A1 Ox40r binding agents
10/09/2003CA2480673A1 Methods and compositions for detection and quantitation of nucleic acid analytes
10/09/2003CA2480664A1 Cancer associated protein phosphatases and their uses
10/09/2003CA2480635A1 Cancer associated protein kinases and their uses
10/09/2003CA2480525A1 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
10/09/2003CA2480434A1 Novel integrated circuit chip for bioassays
10/09/2003CA2480286A1 Disruption of the redk gene
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480216A1 Human metabolic models and methods
10/09/2003CA2480170A1 Hybrid phosphoinositide phospholipids: compositions and uses
10/09/2003CA2480160A1 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
10/09/2003CA2480119A1 Cripto-specific antibodies
10/09/2003CA2480055A1 System and method for managing a patient treatment program
10/09/2003CA2479750A1 Fibrinogen binding moieties
10/09/2003CA2479379A1 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2476352A1 Methods for selecting treatment regimens and predicting outcomes in cancer patients
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448584A1 Integrated sample testing meter
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1351058A1 Fluorescence-based mucus assay
10/08/2003EP1351057A1 Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
10/08/2003EP1351056A2 Specific bonding analysis method and capillary tube device therefor
10/08/2003EP1351055A2 Test strip containers and methods of using the same
10/08/2003EP1351054A2 Installation structure for gas sensor
10/08/2003EP1351053A1 Method for preparing fragrance composition with plurality of sampling ports
10/08/2003EP1350855A2 Array based hybridization assays
10/08/2003EP1350851A1 Method of detecting polymorphism in dna by using mass spectroscopy
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350847A1 Human glioma antigen and process for preparing the same
10/08/2003EP1350839A1 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350568A1 Biochannel assay for hybridization with biomaterial
10/08/2003EP1350464A1 Method of verifying the efficacy of a skin product
10/08/2003EP1350333A2 Local oscillator leakage control in direct conversion processes
10/08/2003EP1350179A2 Methods and systems for evaluating a matching between measured data and standards
10/08/2003EP1350121A2 Sea-trosy and related methods
10/08/2003EP1350116A1 Method of compensating for drift in gas sensing equipment
10/08/2003EP1350115A2 Structure-based methods for assessing amino acid variances
10/08/2003EP1350114A2 Detection of survivin in the biological fluids of cancer patients
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1350112A2 Methods for the treatment of ibs
10/08/2003EP1350111A2 Detection of allergen-specific ige
10/08/2003EP1350110A2 Methods for conducting assays, and devices for use therein
10/08/2003EP1350109A1 Marker for inflammatory conditions
10/08/2003EP1350108A2 Method for identifying a ligand for a biological substrate
10/08/2003EP1350107A2 Method and device for characterising and/or for detecting a bonding complex
10/08/2003EP1350106A2 Ultra-sensitive detection systems
10/08/2003EP1350105A2 Immunoassays for anti-hcv antibodies
10/08/2003EP1350104A2 Presenilin enhancers
10/08/2003EP1350102A2 Detection of analytes
10/08/2003EP1350101A2 Morphometric tissue or cell preparation
10/08/2003EP1350100A2 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
10/08/2003EP1350099A1 Device for measuring blood coagulation and method thereof